L. Kilburn

Fluoroquinolone Resistance in Clinical Isolates ofStreptococcus pneumoniae: Contributions of Type II Topoisomerase Mutations and Efflux to Levels of Resistance

L. Mandell, D. Low, J. D. de Azavedo, 2000, Antimicrobial Agents and Chemotherapy.

A nosocomial outbreak of fluoroquinolone-resistant Streptococcus pneumoniae.

D. Low, A. McGeer, M. Laverdière, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Genetic Locus for Streptolysin S Production by Group A Streptococcus

V. Nizet, D. Low, V. Datta, 2000, Infection and Immunity.

Interspecies Recombination Contributes Minimally to Fluoroquinolone Resistance in Streptococcus pneumoniae

L. Mandell, D. Low, J. D. de Azavedo, 2001, Antimicrobial Agents and Chemotherapy.

Relative Potential for Selection of Quinolone-Resistance- Determining-Region Mutations in Streptococcus pneumoniae by Gemifloxacin, Gatifloxacin and Moxifloxacin

J. Downar, D. Low, D. Bast, 2006, Journal of chemotherapy.